Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)

Clinical trial NCT00700206 · COMPLETED

Trial details

NCT number: NCT00700206
Sponsor: Telik
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome (MDS)

Start date: 2008-05-01
Primary completion: 2011-07-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.